Elusys Therapeutics, Inc
Elusys Therapeutics, Inc., located in Parsippany, NJ, is dedicated to developing innovative medical countermeasures that provide effective and durable protection against infectious agents and public health threats. The company focuses on accelerating the development and commercialization of novel biodefense solutions, particularly in collaboration with strategic government partners.
One of Elusys's key products is ANTHIM (obiltoxaximab), a monoclonal anthrax antitoxin designed to mitigate the effects of anthrax exposure. With over $450 million in procurement and development contracts from various government agencies, Elusys has successfully advanced ANTHIM to the commercial stage, contributing to U.S. biosecurity efforts against potential anthrax attacks.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

